ELIZA
ELIZA is an early natural language processing computer program created from 1964 to 1966 at the Massachusetts Institute of Technology (MIT) by Joseph Weizenbaum. ELIZA was one of the first programs capable of attempting the Turing test, which evaluates a machine's ability to exhibit intelligent behavior equivalent to, or indistinguishable from, that of a human.
Development
ELIZA was developed to demonstrate the superficiality of communication between humans and machines. The program used pattern matching and substitution methodology to simulate conversation. It was named after Eliza Doolittle, a character from George Bernard Shaw's play Pygmalion, which was later adapted into the musical My Fair Lady.
Functionality
ELIZA operated by processing user inputs and responding with pre-defined scripts. The most famous script, known as "DOCTOR," simulated a Rogerian psychotherapist. This script worked by rephrasing many of the user's statements as questions, encouraging the user to continue the conversation.
Impact and Legacy
ELIZA's creation marked a significant milestone in the field of artificial intelligence (AI) and natural language processing (NLP). It demonstrated that machines could be programmed to interact with humans in a seemingly meaningful way, even if the understanding was superficial. ELIZA influenced the development of later AI programs and chatbots, including PARRY, ALICE, and modern virtual assistants like Siri and Alexa.
Criticism
Despite its innovative approach, ELIZA faced criticism for its limitations. Critics argued that the program's responses were formulaic and lacked genuine understanding. Weizenbaum himself was critical of the misuse of ELIZA, particularly in the field of psychotherapy, where he believed it could not replace human therapists.
See Also
- Artificial intelligence
- Natural language processing
- Turing test
- Chatbot
- Joseph Weizenbaum
- Rogerian psychotherapy
References
External Links
This article is a artificial intelligence-related stub. You can help WikiMD by expanding it!
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD